Expansion into Medical, Pharmaceuticals, Biotechnology, Food, and Social Infrastructure
First written in FY2016. 16 of 33 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-09-11.
The whole theme swung hardest in 2025: 5 of 24 companies on the "Worse" side.
13 other companies' latest entry also says "Advanced".
- 2026-09-11AdvancedM&A and Subsidiary Changes
「We have set out a policy of promoting expansion into four fields: industrial robots, medical equipment, food and pharmaceutical inspection, and social infrastructure.」
The company specifically identified industrial robots, medical equipment, food and pharmaceutical inspection, and social infrastructure as the four target fields for expansion into new areas. - FY2026Recovery in demand related to medical and power infrastructure, with continued overall sales declines by product categoryAnnual report
「Although stagnation in factory automation (FA)-related business continued and some customers in the medical equipment and power-related fields showed a recovery in demand, overall sales declined year on year. Net sales therefore amounted to ¥536 million, down 13.2% year on year.」
Although some customers in the medical equipment and power-related fields showed a recovery in demand, total embedded-module sales declined 13.2% year on year owing to stagnation in factory automation (FA)-related business. - 2026-06-03RestatedGeneral Meetings of Shareholders
「We will promote the development of new markets and customers, particularly in the medical, pharmaceutical, food and social infrastructure sectors.」
Expansion into the medical, pharmaceutical, food and social infrastructure sectors was reiterated as a priority area for new market development. - FY2026-H1Recovery in medical and power-related demand alongside an overall decline in product salesAnnual report
「Although stagnation in factory automation (FA)-related business continued, some customers in the medical equipment and power-related fields showed a recovery in demand, and overall performance was slightly above expectations. Net sales therefore amounted to ¥229 million, down 20.4% from the previous interim accounting period.」
Although some customers in the medical equipment and power-related fields showed a recovery in demand, total embedded-module sales declined 20.4% year on year owing to stagnation in factory automation (FA)-related business. - FY2025-H1AdvancedAnnual report
「Business exceeded expectations, mainly in medical equipment and power-related applications. Net sales therefore amounted to ¥288 million, down 4.9% from the previous interim accounting period.」
For embedded modules, demand for medical equipment and power-related applications exceeded expectations. Total product sales declined 4.9% year on year, with strong performance in the target fields occurring alongside an overall decline in sales. - FY2024AdvancedAnnual report
「This product is supplied for semiconductor manufacturing equipment, medical equipment, factory automation (FA), and power and telecommunications applications. Business exceeded expectations, mainly in medical equipment and power-related applications. Net sales therefore amounted to ¥644 million, up 23.5% year on year.」
Sales of embedded modules for new fields, including medical equipment and power-related applications, amounted to ¥644 million, up 23.5% year on year, demonstrating progress in supplying products for new fields. - FY2024-Q3AdvancedAnnual report
「Business remained firm, mainly in medical equipment and semiconductor manufacturing equipment. Net sales therefore amounted to ¥491 million, up 59.3% year on year.」
Sales of embedded modules, including for medical equipment, amounted to ¥491 million, up 59.3% year on year, and progress in supplying products related to new fields continued. - FY2024-Q2AdvancedAnnual report
「This product is supplied for semiconductor manufacturing equipment, medical equipment, factory automation (FA), and power and telecommunications applications. Business remained generally firm, mainly in medical equipment and semiconductor manufacturing equipment. Net sales therefore amounted to ¥303 million, up 47.5% year on year.」
The company continued supplying embedded modules, including for medical equipment, and net sales increased 47.5% year on year. - FY2024-Q1AdvancedAnnual report
「Embedded modules are supplied for semiconductor manufacturing equipment, medical equipment, factory automation (FA), and power and telecommunications applications. Business remained firm, mainly in medical equipment and semiconductor manufacturing equipment. Net sales therefore amounted to ¥171 million, up 117.6% year on year.」
The company continued supplying embedded modules, including for medical equipment, and net sales increased 117.6% year on year. The company described progress in supplying products related to new fields. - FY2023AdvancedAnnual report
「This product is supplied for semiconductor manufacturing equipment, medical equipment, factory automation (FA), and power and telecommunications applications. Orders, including those for medical equipment and semiconductor manufacturing equipment, remained firm. Net sales therefore amounted to ¥521 million, up 39.1% year on year.」
Orders for embedded modules, including those related to medical equipment, remained firm, and net sales increased 39.1% year on year. The full-year results show product deliveries related to new fields. - FY2023-Q3AdvancedAnnual report
「Orders, including those for medical equipment and telecommunications equipment, remained firm. Net sales therefore amounted to ¥308 million, up 22.1% year on year.」
Orders for medical and telecommunications equipment related to the expansion into new fields remained firm, and sales of embedded modules increased 22.1% year on year. - FY2023-Q2AdvancedAnnual report
「Orders, including those for medical equipment and telecommunications equipment, remained firm. Net sales therefore amounted to ¥205 million, up 35.6% year on year.」
Orders for medical equipment and telecommunications equipment remained firm, and embedded-module sales amounted to ¥205 million, up 35.6% year on year. - FY2022RestatedAnnual report
「Alongside expansion into new fields, the company will provide new value by responding to a range of inspection requirements and making proposals involving IoT and big data.」
The company continues its policy of providing new value through expansion into new fields, responses to inspection requirements, and proposals involving IoT and big data. - FY2022-Q2RestatedAnnual report
「Sales of various inspection systems remained at a high level, supported by the active development of new products and growing demand for automation of inspection processes, while customer demand also improved. Net sales therefore amounted to ¥877 million, up 28.3% year on year.」
The company continued developing new products for inspection systems and responding to demand for automation, and sales of image-processing modules increased 28.3% year on year. No new target fields or completed milestones have been identified. - FY2021-Q3RestatedAnnual report
「Orders for medical equipment and power and telecommunications equipment remained firm, but net sales declined.」
The company continues to state that orders for medical equipment and power and telecommunications equipment remain firm, but total embedded-module sales declined year on year. - FY2021-Q2RestatedAnnual report
「Orders for medical equipment and power and telecommunications equipment remained firm, but net sales declined.」
The company continues to state that orders for medical equipment and power and telecommunications equipment remain firm, while embedded-module sales declined 9.8% year on year. - FY2021-Q1RestatedAnnual report
「This product is supplied for semiconductor manufacturing equipment, medical equipment, factory automation (FA), and power and telecommunications applications. Orders for medical equipment and power and telecommunications equipment remained firm, but net sales declined.」
The company continues to state that orders for medical equipment and power and telecommunications equipment remain firm, while total embedded-module sales declined 20.6% year on year. - FY2020AdvancedAnnual report
「Orders across factory automation (FA) and medical equipment-related fields remained firm, resulting in higher net sales. Net sales therefore amounted to ¥445 million, up 4.1% year on year.」
New orders, including those related to medical equipment, remained firm, and sales of embedded modules increased 4.1% year on year. - FY2020-Q3AdvancedAnnual report
「New orders across factory automation (FA) and medical equipment-related fields remained firm, resulting in higher net sales. Net sales therefore amounted to ¥313 million, up 10.8% year on year.」
New orders across factory automation (FA) and medical equipment-related fields, which are part of the expansion into new fields, remained firm, and sales of embedded modules increased 10.8% year on year. - FY2020-Q2AdvancedAnnual report
「New orders across factory automation (FA) and medical equipment-related fields remained firm, resulting in higher net sales. Net sales therefore amounted to ¥218 million, up 29.3% year on year.」
New orders, including those related to medical equipment, remained firm, and sales of embedded modules increased 29.3% year on year. - FY2020-Q1AdvancedAnnual report
「New orders across factory automation (FA) and medical equipment-related fields remained firm, resulting in higher net sales. Net sales therefore amounted to ¥103 million, up 21.9% year on year.」
As part of its expansion into new fields, new orders related to medical equipment remained firm, and sales of embedded modules increased 21.9% year on year. - FY2019RestatedAnnual report
「We will continue to invest management resources actively in our core business fields of semiconductor manufacturing equipment, industrial control equipment and measuring instruments, strengthen proposal-based products built on our proprietary product technologies, and pursue higher added value. We are also pursuing expansion into new fields, including medical, pharmaceutical, biotech, food and big data.」
The company continues to expand into new fields, including medical, pharmaceuticals, biotechnology and food, while continuing to allocate management resources to its core businesses. - FY2019-Q3RestatedAnnual report
「Capital investment across the industrial equipment sector is on a recovery trend. In addition, expansion into new fields progressed smoothly, and proprietary products as a whole performed well.」
The company continues to state that expansion into new fields is progressing smoothly. No new target fields or completed milestones have been identified. - FY2019-Q2RestatedAnnual report
「Capital investment across the industrial equipment sector is on a recovery trend. In addition, expansion into new fields progressed smoothly, and proprietary products as a whole performed well.」
The company continues to state its existing policy and position that expansion into new fields is progressing smoothly. - FY2019-Q1RestatedAnnual report
「Capital investment across the industrial equipment sector is on a recovery trend, and expansion into new fields also progressed smoothly, resulting in higher sales of proprietary products overall.」
The company continues to state that its expansion into new fields is progressing smoothly, but has not identified any new target fields or completed milestones. - FY2018RaisedAnnual report
「We will continue to invest management resources actively in our core business fields of semiconductor manufacturing equipment, industrial control equipment and measuring instruments, strengthen proposal-based products built on our proprietary product technologies, and pursue higher added value. We are also pursuing expansion into new fields, including medical, pharmaceutical, biotech, food and big data.」
In addition to the existing fields of medical, pharmaceuticals and biotech and food, the company identifies big data as a new field, broadening the scope of its development targets. - FY2018-Q3AdvancedAnnual report
「In addition to actively promoting the development of new products for various inspection equipment, expansion into new fields such as food and pharmaceuticals progressed smoothly, and sales increased significantly. As a result, sales were ¥1,069 million, up 57.4% year on year.」
Expansion into new fields such as food and pharmaceuticals continued to progress, and sales of image-processing modules were ¥1,069 million, up 57.4% year on year. - FY2018-Q2AdvancedAnnual report
「In addition to actively promoting the development of new products for various inspection equipment, expansion into new fields such as food and pharmaceuticals progressed smoothly, and sales increased significantly. As a result, sales were ¥636 million, up 50.5% year on year.」
Expansion into new fields such as food and pharmaceuticals progressed smoothly, and sales of image-processing modules increased 50.5% year on year. - FY2018-Q1RestatedAnnual report
「Capital investment across the industrial equipment sector is on a recovery trend, and expansion into new fields also progressed smoothly, resulting in higher sales of proprietary products overall.」
The company continues to state that development of new fields has progressed smoothly. - FY2017-Q3RestatedAnnual report
「In addition to actively promoting the development of new products for various inspection equipment, expansion into new fields such as food and pharmaceuticals progressed smoothly, and sales increased.」
The company continues to state that development of new fields such as food and pharmaceuticals has progressed smoothly. - FY2017-Q2RestatedAnnual report
「In addition to actively promoting the development of new products for various inspection equipment, expansion into new fields such as food and pharmaceuticals progressed smoothly, and sales increased.」
The company continues to state that development of new fields such as food and pharmaceuticals has progressed smoothly. - FY2017-Q1AdvancedAnnual report
「Capital investment across the industrial equipment sector is on a recovery trend, and expansion into new fields also progressed smoothly. However, sales of proprietary products as a whole declined slightly.」
The company states that development of new fields progressed smoothly, indicating progress under its existing plans, including food and pharmaceuticals. - FY2016First statedAnnual report
「We are also pursuing expansion into new fields, including medical, pharmaceutical, biotech, food and social infrastructure.」
In addition to the existing semiconductor manufacturing equipment, industrial control equipment and measuring instruments businesses, the company specifically identifies multiple new industries as targets for development.